Cerliponase alfa is a treatment for late neonatal ceroid lipofuscinosis type 2 (CLN2) to reduce the rate at which motor function declines. The following article provides you with information about the uses and precautions when using Cerliponase alfa.

Batten disease is a group of rare neurological disorders that get worse over time. They usually begin between the ages of 5 and 10. Although there are many different forms of the disease, all are fatal, usually in the teens or 20s.